Global Primary Progressive Multiple Sclerosis Treatment Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Primary Progressive Multiple Sclerosis Treatment Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Primary Progressive Multiple Sclerosis Treatment
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Primary Progressive Multiple Sclerosis Treatment Market by Type

• 3.1 By Type
  • 3.1.1 ApE
  • 3.1.2 Biotin
  • 3.1.3 GZ-402668
  • 3.1.4 Ibudilast
  • 3.1.5 Idebenone
  • 3.1.6 Laquinimod Sodium
  • 3.1.7 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Primary Progressive Multiple Sclerosis Treatment F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)

• 4.2 Genzyme Corporation (Company Profile, Sales Data etc.)
• 4.3 Glialogix, Inc. (Company Profile, Sales Data etc.)
• 4.4 Kyorin Pharmaceutical Co., Ltd. (Company Profile, Sales Data etc.)
• 4.5 MedDay SA (Company Profile, Sales Data etc.)
• 4.6 Santhera Pharmaceuticals Holding AG (Company Profile, Sales Data etc.)
• 4.7 Teva Pharmaceutical Industries Ltd. (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Hospital
  • 6.1.2 Demand in Clinic
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Primary Progressive Multiple Sclerosis Treatment

Table Application Segment of Primary Progressive Multiple Sclerosis Treatment

Table Global Primary Progressive Multiple Sclerosis Treatment Market 2013-2024, by Application, in USD Million

Table Major Company List of ApE

Table Major Company List of Biotin

Table Major Company List of GZ-402668

Table Major Company List of Ibudilast

Table Major Company List of Idebenone

Table Major Company List of Laquinimod Sodium

Table Major Company List of Others

Table Global Primary Progressive Multiple Sclerosis Treatment Market 2013-2018, by Type, in USD Million

Table Global Primary Progressive Multiple Sclerosis Treatment Market 2013-2018, by Type, in Volume

Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2019-2024, by Type, in USD Million

Table Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 2019-2024, by Type, in Volume

Table F. Hoffmann-La Roche Ltd. Overview List

Table Primary Progressive Multiple Sclerosis Treatment Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Genzyme Corporation Overview List

Table Primary Progressive Multiple Sclerosis Treatment Business Operation of Genzyme Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Glialogix, Inc. Overview List

Table Primary Progressive Multiple Sclerosis Treatment Business Operation of Glialogix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Kyorin Pharmaceutical Co., Ltd. Overview List

Table Primary Progressive Multiple Sclerosis Treatment Business Operation of Kyorin Pharmaceutical Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table MedDay SA Overview List

Table Primary Progressive Multiple Sclerosis Treatment Business Operation of MedDay SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Santhera Pharmaceuticals Holding AG Overview List

Table Primary Progressive Multiple Sclerosis Treatment Business Operation of Santhera Pharmaceuticals Holding AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Pharmaceutical Industries Ltd. Overview List

Table Primary Progressive Multiple Sclerosis Treatment Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue 2013-2018, by Company, in USD Million

Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Share, by Company, in USD Million

Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume 2013-2018, by Company, in Volume

Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2019-2024, by Application, in USD Million

Table Primary Progressive Multiple Sclerosis Treatment Demand Forecast 2019-2024, by Application, in Volume

Table Primary Progressive Multiple Sclerosis Treatment Production 2013-2018, by Region, in USD Million

Table Primary Progressive Multiple Sclerosis Treatment Production 2013-2018, by Region, in Volume

Table Global Primary Progressive Multiple Sclerosis Treatment Market 2013-2018, by Region, in USD Million

Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2013-2018, by Region, in USD Million

Table Global Primary Progressive Multiple Sclerosis Treatment Market 2013-2018, by Region, in Volume

Table Global Primary Progressive Multiple Sclerosis Treatment Market Share 2013-2018, by Region, in Volume

Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in USD Million

Table North America Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in Volume

Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in USD Million

Table Europe Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in Volume

Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in USD Million

Table South America Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size 2013-2018, by Country, in Volume

Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2019-2024, by Region, in USD Million

Table Primary Progressive Multiple Sclerosis Treatment Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2013-2018, by Type, in USD Million

Figure Global Primary Progressive Multiple Sclerosis Treatment Market Growth 2013-2018, by Type, in Volume

Figure North America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2018

Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Market Concentration, in 2018

Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment MMarket Concentration, in 2018

Figure South America Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2018

Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Concentration, in 2018

Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2013-2018, in USD Million

Figure Primary Progressive Multiple Sclerosis Treatment Demand in Hospital, 2013-2018, in Volume

Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2013-2018, in USD Million

Figure Primary Progressive Multiple Sclerosis Treatment Demand in Clinic, 2013-2018, in Volume

Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2013-2018, in USD Million

Figure Primary Progressive Multiple Sclerosis Treatment Demand in Others, 2013-2018, in Volume

Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in USD Million

Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in Volume

Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in USD Million

Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in Volume

Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in USD Million

Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview